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Using Reproductive Effect Markers to
Observe Subclinical Events, Reduce
Misclassification, and Explore
Mechanism
by Maureen C. Hatch* and George Friedman-Jimenez*
Biological markersofeffect, ingeneral lesswidelyavailablethan exposuremarkers, doexist in the fieldofreproduc-
tion andincreasingly arebeing usedinepidemioogical studies. Several suchmarkers, including semen quality, menstrual
hormones, early pregnancyloss, andplacentalabnormalities, arecited asexamples. Wearguethevalueofeffectmarkers
fordetecting subclinical eventsthat arecritical forreproductive performance. Such studies canextendknowledge ofthe
true frequency and determinates ofreproductive disorders. A second portion ofthe paper deals with the role ofeffect
markers inreducingdiseasemisclassification. With ahypothetical early pregnancy study asa case in point, weillustrate
thedegreeanddirectionofbiasassociatedwithseveraldifferentprotocolsandencourageepidemiologists toweighthese
quantitative considerations in deciding on study design. Finally, we discuss uses of biological markers to explore
mechanisms, drawing onexperienceinanongoingreproductivestudythatistestingahypothetal pathwayfrom maternal
psychosocial stress to reduced fetal growth usingurinecatecholamine levels as a physiological marker ofexposure and
placental vascular abnormalities as a marker ofeffect.
Introduction
Biological markers, ifthey arewell chosen, canbeimportant
aids for discovering, describing, and interpreting associations
between exposure and disease. The field of reproductive
epidemiology is fortunate to have available a number of
biologicaleffectmarkers. Table 1 gives selectedexamples. The
term "effectmarker" isusedhere to mean anychange indicative
ofaproblem(acorrelate, a precursor, anoccultevent). For some
ofthemarkers inTable 1, likematernal serumalphafetoprotein
screening orcomputer-assisted semen analysis, there is a fair-
ly broad base of experience in population studies. For other
markers, like menstrual and pregnancy hormones, use in field
settings is onlyjust beginning. We discuss past and future ap-
plications ofbiological markers foradversereproductive effects
inthecontextofthreetopics: observingsubclinicalevents, classi-
fying outcome accurately and exactly, and investigating
pathogenesis.
Observing Subclinical Events
The events surrounding fertilization and early pregnancy,
whilecrucialtoreproductive performance, arelargelyunobserv-
able. The moreinterestthereis inresearch onfertility, the more
important aremethods for measuring reproductivepotential in
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males and females and the circumstances ofearly pregnancy.
Semen Analysis
Clinical tools forevaluating testicular function in males were
firstapplied topopulationstudies over adecade ago (1). Taking
a technique based on semen samples into the field presented
serious challenges, and research protocols have evolved con-
siderably overtime. Requirements forcollecting and transpor-
ting semen specimens are nowbetterdefinedand moreuniform
across studies. Normal values and ranges for measured sperm
parameters havebeenestablished. Technological improvements
such ascomputerized automationhaveextended semenanalysis
capabilities to moresitesandhavehelped to standardizeanalytic
Table 1. B ll markersofrepductive dfects: selectedexamples.
System Marker
Male reproductive function Semenanalysis
Fertilizing capacity invtro
Follicle-stimulating hormone,
luteinizing hormone
Female reproductive function Human luteinizing hormone surge;
estrogen: progesterone
Salivary,vaginalelectricalresistence
Pregnancy and loss Humanchorionic gonadtropin
? Earlypregnancy fictor
Embryo, fets, and neonate Matenal serumalphafetoprotein
Karyotyp
Placentl histology, morphologyH26CH ANDFRIEDMAN-JIMENEZ
results from laboratory to laboratory. With the useofportable
equipment, ithas become feasible toevaluate important time-
dependent sperm characteristics such as velocity and motility
outsidetheclinicalsetting(2). Oneinvestigatorhasevenapplied
sophisticated in vitrobioassaysofspermfertlizationcapacity in
fieldresearchusing anewmethodforpreservingand shipping
specimens toanoffsite laboratory (3).
Asamarker, semenanalysishasprovedusefulforassessingthe
reproductive toxicity of a variety of exposures, particularly
workplaceagents (4). Whilethequantitative relationsofsemen
quality to couple fertility are not firmly established, on a
qualitativelevel anassociation hasbeendemonstrated (5), and
artificialinseminationprogramsselecttheirdonorsaccording-
ly, forhighspermcountandfunction. Thus, despitesomeuncer-
tainty about the clinical significance of observed changes in
specific sperm parameters, semen quality is generally con-
sidered auseful marker.
Menstrual Disorders
Just as male reproductive potential is reflected in the in-
seminate, so female reproductive potential is indicated by the
adequacy ofthe follicular, ovulatory, and luteal phases ofthe
menstrualcycle. Fertility infemales isclearly decreased when
there is substantial menstrual cycle variability, as in the
postpubertal (6) and perimenopausal (7) periods. But even
regular menses can maskovulatory disorders (8), luteal phase
defects (9), orearlypregnancy loss(10). Becauseofthemarked
fluctuations characteristicofthecycle, adetailedhormonalpro-
fileoncerequiredserialbloodsamples, whichwerefeasibleonly
inaclinical setting. Withtheadventoflessinvasivetechniques
thatutilize urine (11) and saliva (12) instead ofblood, it is now
possible tocontemplate inclusionofendocrineprofiles infield
studies (13).
Menstrualdisordersareimportantintheirownright, aswell
asinrelationtofertilityandriskofchronicdiseasesthatarein-
fluencedby reproductivehormones. Aresearchapproachbased
on hormonal evaluation will more fully ascertain menstrual
disorders andmay indicateanunderlyingcause, butitdemands
collectionofbiologicalsamplesasoftenasdaily. Someworkof
thiskindhasbeendoneinthecontextofresearchonpopulation
controlinordertodelimitthefertileperiodordocumentreturn
tofertilitypostlactation(14). Evaluationofmenstrualhormones
(luteinizinghormone, estgen, progesterone) wasincluded in
alandmark study ofearly pregnancy lossby AllenWilcox and
colleagues (10), andhasbeenproposedinconjunction withother
early pregnancy studies currently in planning or in progress.
Such workutilizing ovarianmarkers shouldcontribute impor-
tantly to anunderstanding offemalereproductive function.
Early Pregnancy andPregnancy Less
The rate of attrition among human conceptions is extraor-
dinarilyhigh, andmostoftheloss occurspriortotheexpected
onsetofmenses, whenpregnancymightfirstberecognized(15).
Onemarkerofpregnancy, theso-called fetal signal, isthepro-
duction by the trophoblast of hCG (human chorionic
gonadotropin), a glycoprotein hormone with a structure and
function similar to hLH (humanluteinizing hornone). Ifcon-
ceptionoccurs, hCGcanbedetectedasearlyas7to8daysafter
ovulationoraroundthetimeofimplantation. Althoughlevelsof
hCG are similar in blood and urine, it is only recently that
urinaryassayshaveapproachedthesensitivityandspecificityof
testsonserum. Withthisdevelopment, theepidemiologyofearly
pregnancy andearly losscanbegin tobeexploredonthebasis
ofriseand fall inhCG across serial urine samples.
TheinitialfieldstudiesapplyingurinaryhCGasamarkerof
pregnancyproducedwidelydivergentestimatesofthefrequency
ofclinically inapparentfetalloss(16-18), atleastinpartbecause
thehCGassaysusedwereinsensitiveand/orcross-reactivewith
hLH. MorerecentworkbyWilcoxattheNationalInstituteofEn-
vironmental HealthSciences incollaborationwithresearchers
at Columbia University who developed ahighly sensitive and
specifichCGassay (19) setanew stadardforearlypregnancy
studies. Analysesofurinescollecteddailyfromover200healthy
volunteersdocumentedearlyinapparentlossesinapproximately
22% ofhCG-detected conceptions. The total rate of loss, in-
cluding recognized miscarriage, was 31% (10). Now that the
groundhasbeenlaid, futureworkcanexaminethecausesofoc-
cultpregnancylossandtheroleitplaysinconceptiondelayand
clinical infertility.
Logistical Issues
Thereistremendousinterestinstudyingearlypregnancy, but
logisticalissuesloomlargeforepidemiologists. Thecollection
ofdailyurines, whetherformeasuring hCGormenstrual hor-
mones,isaformidabletask. Inevitably,thereisatensionbetween
idealprotocols(idealintermsofthedataonewouldwishtocol-
lect)andaprotocolthatisacceptabletopotential study subjects.
Acceptability is a limiting factor because nonparticipation
(whetherthroughinitialrefusalsorattrition)willalmostalways
introduceaselectionbias, theextentanddirectionofwhichcan
behardtoevaluateexceptonajudgmentalbasis(20). Toavoid
poor response rates and the resulting threat ofselection bias,
severalstrategiesforearlypregnancyresearchhavebeenbruited.
Theapproachescanbeappliedtoanyreproductiveresearchus-
ingmarkersthatrequire serial samples.
Onestrategyhasbeentorestrictattentiontohighlymotivated
subgroups, forexample, infertilitypatientsorwomenplanning
apregnancywhovolunteertheirparticipation. Thislattergroup
was98% compliantwithaprotocolrequiringdailyurinesforup
to6months(21). Thelimitationoftheapproachisthatforsome
questionstheresultsobtainedinselectedsubgroupsmaynotap-
plytothegeneralpopulation. Analternativeistorecruitfroma
wider population base but to use tests or sample collection
strategies that impose fewer demands on study subjects and
shouldthereforebecommensuratewithgoodparticipationrates.
Theriskisthatusingmarkersinthiswaymaycompromisetheir
sensitivity or specificity. Whether to use a biological effect
markeratall, andifso, howtouseit, isanissuethatcanusual-
lybedecided inthecontextofdisease misclassification.
Classifying OutcomeAccurately
and Exactly
Thatnondifferential misclassification ofsubjectsbyexposure
attenuatesestimatesofeffectiswidelyrecognized (22). Tabular
orgraphicaldataareavailabletoepidemiologistsforquantifying
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the bias introduced by different rates and types of exposure
misclassification (20,23,24). The prospect ofremediating this
bias is a compelling and frequently cited reason for interest in
biomarkers ofexposure.
Misclassificationofdisease, asopposedtoexposure, isatopic
discussedlessoften. Although someworkhasbeendone(25,26),
wecouldlocatenoquantitativedataonhowmisclassificationaf-
fects measures ofassociation. As such figures are essential to
evaluating the costs ofdiseasemisclassification, wedeveloped
asetoftables describinghow error inmeasuringoutcomewill
bias effect estimates. The tables (available upon request) were
generatedusingKleinbaum, Kupper, andMorgenstem'sgeneral
equations for misclassification (26). Estimates ofdegree and
directionofbiasweredevelopedforbothnondifferentialanddif-
ferentialcasesandforcase-control andcohortdesigns. Herewe
draw on this material as a framework for discussing the use of
markersofearlypregnancyandearlyloss. Inthediscussion, sen-
sitivity andspecificity refertotheaccuracyofdiseaseclassifica-
tion compared to a diagnostic gold standard, which in this ap-
plication is the currently most accuratebiological marker.
Ingeneral, fornondifferential misclassificationofdisease, as
forexposure, poor specificity will causegreaterattenuation of
risk estimates than poor sensitivity. Specificity is decreased
when the truly nondiseased are misclassified as diseased. This
could arise, for example, with use of an hCG assay that
crossreacts with hLH. Even with a highly specific assay, there
is riskofthistype ofmisclassification ifurines arecollectedless
oftenthandaily (e.g., ifthe schedule is suchthatatransientpeak
in hCG could be interpreted as a sustained rise).
Take the hypothetical case ofa prospective early pregnancy
study. Assume an exposure prevalence of 20% (perfectly
classified, for simplicity) anda20% frequency ofclinically in-
apparent loss intheunexposed. Using an assay with sensitivity
of99% for detecting loss after implantation and with nondif-
ferential specificity of 80% (i.e., with a uniform 20%
misclassification oftrulynondiseasedasdiseased), atruerelative
risk (RR) of2.00wouldbeattenuated to 1.44and atrue relative
riskof3.00wouldbeattenuatedto 1.88. Thus, forcompromises
inprotocol that threaten specificity, there is a fairly substantial
biastowardthenullhypothesis thatincreases withthe sizeofthe
true effect and the rarity ofdisease.
Now supposethataspecificity of99% canbeassuredbutthat
the choice of marker or of strategy for collecting biological
samples leadstosuboptimal sensitivity. Letusagainconsider the
hypothetical early pregnancy study butthis timeusing an assay
(e.g., acommercial pregnancy kit)thathasanondifferential false
negative rate on the order of20% (that is, sensitivity equal to
80%). Foratrue RRof2, theestimated RR wouldbe 1.94. For
anRRof3, theestimatewouldbe2.88. With asensitivity onthe
orderof80% there isattenuation, butitisconsiderably lessthan
intheprevious example, where specificity was 80%. Inreal life,
sensitivity ofdisease classification may vary much more than
specificity (down to levels as low as40%) and under these cir-
cumstancescouldproduceconsiderableattenuation. Lower sen-
sitivity alwaysmeansascertaining fewerevents, sotherewillalso
be a loss in precision.
Thecaseofdifferential misclassification ismorecomplexthan
thenondifferential caseandhencedifficult tosummarize. An ex-
ample will serve to illustrate the possible biases. Suppose an
exposure under test preferentially causes early loss. We can
estimatethebias thatwill occur ifoutcome is determined only
on the basis of self-report or medical records of recognized
miscarriageratherthanwithabiochemical assay. Assumeatrue
riskofpregnancylossintheunexposedof30%, usingestimates
ofloss based on urinary hCG as the gold standard (10). Then
assumethatclinicaldiagnosisofpregnancylosshasaspecificity
of98% inboththeexposedandunexposed. Ifexposurecauses
earlylosspreferentially, theclassificationofdiseasestatuswill
beless sensitiveforexposedwomenthanforunexposedwomen.
Agreaterproportionoflossesoccurring intheexposed will go
undetected because the exposure will have increased the in-
cidenceofclinicallyinapparentloss. Thus, sensitivityinthe50%
rangefortheunexposedwillbereducedintheexposedto40%.
AtrueRRof2wouldinthiscasebeattenuatedto 1.51. Atasen-
sitivityof30% intheexposed, theRRwouldbeestimatedas 1.15.
Attenuation will be even greater if the true RR is larger, if
specificity is lower, or if exposure is nondifferentially
misclassified. To retain equivalent precision, sample size re-
quirements willbeaboutdoublewhatwouldbeneededhadloss
been measured with urinary hCG.
Differential misclassification can operate in theotherdirec-
tiontoo. Exposedwomenmayoverreportpregnancylossthrough
a greater propensity to interpret menstrual irregularity as a
miscarriage. This wouldincrease sensitivity intheexposed. In
addition, because theoverreporting wouldgenerate more false
positives, specificity wouldbedecreased. Thesebiases areinthe
same direction. Butin somecases, biases canoperateinopposite
directions with an overall effect that is unpredictable in the
absence of a biological marker or some other gold standard.
When misclassification is differential, the bias can be severe
enough to show an apparent protective effect when the true
relative risk is 2, 3, or even 10.
The usefulness and cost-effectiveness ofabiological marker
in improving bothvalidity andprecision ofastudy can often be
judged semi-quantitatively when making decisions on study
design. Biological markers can be used for all subjects in the
study. Or, ifcost oracceptability is prohibitive, markers can be
used in apilotstudy or on arandom sampleofthe studypopula-
tiontoestimate sensitivity and specificity oftheless accurate out-
come measure. Techniques for correcting bias using such
estimates have been proposed (25,26). However, the estimates
basedonsmall samples may notbesufficiently precise to remove
thebias completely. Nonetheless, the information obtained will
help to indicate the direction and degree ofbias.
Wehavediscussedtherolethatreproductiveeffectmarkers can
play in observing subclinical events and in reducing disease
misclassification. They alsohavepotential uses forinvestigating
pathogenesis.
Investigating Pathogenesis
While some maintainthatepidemiology isthestudy ofcauses
and not mechanisms (27,28), we believe that epidemiologists
should try totakemechanism into account as a means ofidenti-
fying and interpreting exposure-effectrelationships (29-32). In
theendeavortogiveepidemiology mechanistic underpinnings,
biological markers can be an invaluable aid.
In 1986, webegan recruiting first-trimester prenatal patients
into a longitudinal study of maternal stress during pregnancy,
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Maternal
psychosocial
stress
catecholamines
vasoconstriction, placental
decreased UPBF abnormalities LBW
FIGURE 1. Hypothetcal pahy from materal pychosocial stress to reduced
birthweight in offspring. UPBF, uteroplacental blood flow; LBW, low
birthweight.
designed to test aprespecified hypothesis aboutmechanism of
action. Briefly, we hypothesized that sustained elevations of
catecholamines, the stress hormones epinephrine and
norepinephrine, andthemetabolite MHPG (methoxyhydroxy-
phenylglycol) might, becauseoftheirvasconstricting action, in-
terferewithuteroplacentalbloodflow, whichinturncouldlead
tovasculardamage intheplacenta andultimately to decreased
birthweight and other problems in the offspring (Fig. 1).
Catecholamine concentrations, faoredby many experts as a sen-
sitive and reliable indicator of a stress response (33), are im-
plicated inexperiments withpregnantanimals as anintervening
factorbetween stress andadverse outcome (34,35). Fortunate-
ly, theydo not appear tobealteredby anormal pregnancyuntil
thetimeoflabor(36)andhencecouldbeusedforthepurpose we
intended. A rise in catecholamines results in increased alpha-
adrenergic activity whichmaydirectly causeconstrictionofthe
uteroplacentalarteries. Theincreasedcatecholaminelevelscould
also stimulateproductionofprostaglandins, potentvasoconstric-
tors thathavebeen shownto act onthefeto-placental bed (37).
Amoderatedecrease inuteroplacental blood flowcouldinduce
pathologicchangesintheplacentathatmayadverselyaffectfetal
growth. Table2lists theplacentalvascularabnormalitiesofpar-
ticular interest to us.
In terms of logistics, collection of placental specimens
presented few problems. The main requisite was coordination
withhospitalswheresubjectsdelivered to ensurethatallplacen-
tas would be submitted to us for pathologic examination, ir-
respectiveofpregnancy outcome. Collectionofurine specimens
waspotentially moreproblematic. Althoughtheprotocol asked
subjects toprovide aurinesampleonly onceat astndardpoint
ingestation, werequired afull 24-hrcollection ratherthanthe
moreconvenient first-morning or spotsample. Catecholamine
excretion rates vary atdifferenttimesoftheday. The24-hrcol-
lectionis meanttopreventmissing anytemporalchangeinpeak
levels thatmightbe associated with acute orchronic stress.
Obtaining 24-hr urines from 400 women was, in its way, a
Sisyphean task. But several strategies helped ensure success.
First, amemberofourfield staffoftrained nursesvisitedeach
subject in her home for a review of the urine collection pro-
cedures. Second, inordertodetectpossiblepatternedchangein
catecholamine levels, weapportionedthe24-hrcollection into
three8-hraliquots. Thismadecollection more manageable for
study subjects. Anadditionalbenefitisthatthealiquotsassured
us someusableinformation on womenwhomissedavoiding(we
Table2. Placentalvascularabr li
Primary Secondary
Retroplacental hemorrhage Chronicplacental inflammation
Infarction Hemorrhagic endovasculitis
Intervillous thrombi Change in weight, volume/
Decidual vasculopathy surfacearea
might lose data for one 8-hr. period but not the whole 24 hr).
Third, weprovidedparticipants withadepartnent store shop-
pingbagtouseforcarryingtheurinecollectionmaterials(8-hr
plasticcontainer, icepack, styrofoamcontainer)whentheyleft
homeduringthedayorevening. Finally, becausemood,activi-
ty, smoking, drinking, and diet can influence catecholamine
secretion, wegavethe subjects adiary andaskedthem to keep
a24-hrlogofsuchdata. Thishelpedfocusthemontheurinecol-
lection. As an inducement, we added a section for recording
thoughtsaboutthepregnancyastheymightdoinaconventional
diary.
Wehavenowvirtualycompletedrecruitmentofthefull cohort
of900 subjects. Overall, the participation rate among eligible
womenisabout77%, agoodresponseforalongitudinal study
with ademanding regimen (repeat interviews, blood samples,
andinsomecases, collectionofurinesandplacentas). Financial
incentiveswereofferedtothefirst 100subjectsbutweredropped
afteratestperiodshowedequivalentrecruitmentrateswhenno
compensation was offered. For the subset of400 women who
wereaskedtocollect24-hrurinespecimens, compliancewasa
renarkable96%. Ofthose, 89% haveausable24-hrcollection,
9% have usable 16-hr collections, andthe remaining 2% have
usable8-hrcollections. Analysesofurinespecimensreportedby
subjects to be complete show dopamine and norepinephrine
levels within the normal ranges for 24-hr samples, indicating
adherence toprotocol.
The field and laboratory work for the catecholamine and
placentalcomponentsofthestudyhaveaddedsubstantiallytothe
expense, butthecostsshouldbeoffsetbygainsinunderstanding
thebiologyofpsychosocial stressandtheroleofplacentalabnor-
malities in the pathogenesis of low birthweight and other
perinatal problems. Perhaps effects ofpsychosocial stress on
reproductionarelimitedtowomenwithaheightenedneuroen-
docrine response to stressors. Perhaps stress at the levels ex-
periencedbythestudypopulationofruralandsuburbanwomen
hasnoclinicalconsequences foroffspring. Ifso, aretheremore
subtleeffectsdetectableasplacentalchanges?Socialsupporthas
been suggested to ameliorate the effects of stress (38). Does
social supportdothisatthelevelofphysiologic response? The
incorporationofbiologicalmarkersallowsustoaddressthesein-
teresting andimportantquestions.
Conclusion
There is somecontroversy aboutthereliability, validity, and
overallutilityofbiologicalexposuremarkersinepidemiologic
studies. There is generally less debate about the value of
biological effect markers, and the field ofreproduction is for-
tunatetohaveseveralavailable. Wehavefocusedhereonsemen
quality,menstrualhormones,earlypregnancyloss,andplacental
abnormalities, but there are others, ready for use or under
development, that are discussed in an upcoming reportby the
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National Research Council (39). Thechallenge toreproductive
researchers is to choose and use such markers well. Logistical
andanalyticalproblems ofcollectingand statisticallyevaluating
largevolumesofdatamaybeformidable, butthebenefitsofef-
fect markers (in terms of improving the power, validity, and
cogencyofreproductivestudies)canbequantifiedandwilloften
outweigh the costs. Much remains to be learned about human
reproduction, and we need all the tools atourdisposal.
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ported by training grant #5T32-CA09529 fromthe National Cancer Institute.
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